ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
386.4
Molecular Formula
C23H18N2O4
Notes
Research use only, not for human use.
Receptor
C/EBPα
CAS Number
2041072-41-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
